Publicaciones (58) Publicaciones en las que ha participado algún/a investigador/a

2015

  1. A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma

    Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931

  2. A labor and cost effective next generation sequencing of PKHD1 in autosomal recessive polycystic kidney disease patients

    Gene, Vol. 561, Núm. 1, pp. 165-169

  3. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach

    Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519

  4. Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury

    Blood, Vol. 126, Núm. 7, pp. 915-919

  5. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  6. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer

    Cancer Cytopathology, Vol. 123, Núm. 4, pp. 230-236

  7. Biological Marker Analysis as Part of the CIBERES-RTIC Cancer-SEPAR Strategic Project on Lung Cancer

    Archivos de Bronconeumologia, Vol. 51, Núm. 9, pp. 462-467

  8. Bone metastases in lung cancer: Potential novel approaches to therapy

    American Journal of Respiratory and Critical Care Medicine, Vol. 192, Núm. 7, pp. 799-809

  9. Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency

    Journal of Pathology, Vol. 236, Núm. 2, pp. 210-218

  10. Co-migration of colon cancer cells and CAFs induced by TGFβ1 enhances liver metastasis

    Cell and Tissue Research, Vol. 359, Núm. 3, pp. 829-839

  11. Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

    BMC Genomics, Vol. 16, Núm. 1

  12. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

    Oral Diseases, Vol. 21, Núm. 7, pp. 899-904

  13. Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease

    Clinical Epigenetics, Vol. 7, Núm. 1

  14. Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats

    Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1194-1208

  15. Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482

  16. Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape

    Cell Reports, Vol. 12, Núm. 8, pp. 1300-1313

  17. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism

    Brain Structure and Function, Vol. 220, Núm. 5, pp. 2721-2738

  18. Differential organization of cortical inputs to striatal projection neurons of the matrix compartment in rats

    Frontiers in Systems Neuroscience, Vol. 9, Núm. APR

  19. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum

    Biochemical Pharmacology, Vol. 96, Núm. 2, pp. 131-142

  20. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer

    PLoS ONE, Vol. 10, Núm. 3